This document, prepared on behalf of the SIBioC Protein Working Group, reviews the existing evidence for recommending the measurement of the most important plasma proteins. For each protein, the related chapter includes: a) a brief introduction describing main biological characteristics, b) the presentation of the available evidence, based on retrieved meta-analyses, systematic reviews, and international and national guidelines, and c) recommendations for the test ordering. The scientific evidence was searched on electronic databases (Medline, Cochrane’s database of systematic reviews) and on the websites of scientific societies. Recommendations were classified on the basis of the source of the retrieved evidence as follows: (+++) official National or International guidelines, (++) meta-analyses or systematic reviews, (±) expert opinions and/or clinical practice, and (–) none (not recommended). The following proteins were considered in the paper: albumin, α1 -antitripsin, α1 -acid glycoprotein, α2 -macroglobulin, haptoglobin, β2 -microglobulin, C-reactive protein (both as marker of inflammation and cardiovascular risk), ceruloplasmin, cystatin C, complement factors, rheumatoid factor, ferritin, immunoglobulins (IgA, IgG, IgM, IgD), free light chains, retinol binding protein, soluble transferrin receptor, serum amyloid A, transferrin, and transtyretin.

Indicazioni per la misura delle principali proteine sieriche / M. Graziani, A. Caldini, U. Basile, A. Dolci, S. Ferraro, I. Ferrarotti, I. Infusino, M. Muratore, M. Mussap, L. Obici, P. Pezzati, G. Previtali, D. Szoke, A. Terreni, M. Zaninotto, G. Merlini. - In: BIOCHIMICA CLINICA. - ISSN 0393-0564. - 36:4(2012), pp. 244-267.

Indicazioni per la misura delle principali proteine sieriche

A. Dolci;
2012

Abstract

This document, prepared on behalf of the SIBioC Protein Working Group, reviews the existing evidence for recommending the measurement of the most important plasma proteins. For each protein, the related chapter includes: a) a brief introduction describing main biological characteristics, b) the presentation of the available evidence, based on retrieved meta-analyses, systematic reviews, and international and national guidelines, and c) recommendations for the test ordering. The scientific evidence was searched on electronic databases (Medline, Cochrane’s database of systematic reviews) and on the websites of scientific societies. Recommendations were classified on the basis of the source of the retrieved evidence as follows: (+++) official National or International guidelines, (++) meta-analyses or systematic reviews, (±) expert opinions and/or clinical practice, and (–) none (not recommended). The following proteins were considered in the paper: albumin, α1 -antitripsin, α1 -acid glycoprotein, α2 -macroglobulin, haptoglobin, β2 -microglobulin, C-reactive protein (both as marker of inflammation and cardiovascular risk), ceruloplasmin, cystatin C, complement factors, rheumatoid factor, ferritin, immunoglobulins (IgA, IgG, IgM, IgD), free light chains, retinol binding protein, soluble transferrin receptor, serum amyloid A, transferrin, and transtyretin.
Settore BIO/12 - Biochimica Clinica e Biologia Molecolare Clinica
2012
Article (author)
File in questo prodotto:
File Dimensione Formato  
2012 BC Dolci et al. Raccomandazioni per il dosaggio delle proteine specifiche.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 250.35 kB
Formato Adobe PDF
250.35 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/702747
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 15
  • ???jsp.display-item.citation.isi??? ND
social impact